Eloxx Pharmaceuticals, Inc.

ELOX·OTC·$0.36Share Price as of 11/2·$1MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/05/26 10-KFY 202503/17/26 10-QQ3 ended 09/30/2311/13/23 10-QQ2 ended 06/30/2308/11/23

Disclosures

8-KCurrent report10/22/26 8-KCurrent report08/11/26 8-KCurrent report06/01/26 8-KCurrent report05/01/26 8-KCurrent report08/12/25

Prospectuses and Registrations

424B3Prospectus10/22/26 S-1Registration statement (IPO)09/11/26 424B4Prospectus06/09/26 S-1/ARegistration statement (amended)06/04/26 S-1/ARegistration statement (amended)06/01/26

Proxies

DEF 14CDefinitive information statement05/08/26 PRE 14CPRE 14C04/28/26 DEF 14ADefinitive proxy04/28/23 DEFA14AAdditional proxy materials04/28/23 DEF 14ADefinitive proxy10/31/22

Ownership

Form 3Initial insider ownership10/21/26 Form 4Insider transaction10/21/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership07/27/26

Other

EFFECTRequest for effectiveness09/18/26 CERTCEO/CFO certification06/08/26 EFFECTRequest for effectiveness06/08/26 8-A12B8-A12B06/01/26 DRSDRS03/20/26